Gian Marco Werro

Gian Marco Werro is an equity analyst at Zürcher Kantonalbank, specializing in pharmaceutical and biotechnology sectors. He is known for his insightful analyses of market trends and company performance, particularly in relation to innovative treatments like Nemluvio, which has contributed significantly to Galderma's impressive growth in recent years.